1.50848

LiChrospher^® 100 RP-18 endcapped (10 µm) HPLC Columns

L x I.D. 250 mm x 4 mm, LiChroCART^™ HPLC cartridge, manuCART^™ holder required for use

• Synonym(e): TM=["LiChrospher"] C18 TM=["LICHROCART"] cartridge for HPLC
• UNSPSC-Code: 41115709
• NACRES: SB.52

Eigenschaften

• product name: LiChrospher^® 100 RP-18 endcapped (10 µm) LiChroCART^™ 250-4, suitable for HPLC
• Materialien: stainless steel column
• Qualitätsniveau: 100
• Agentur: suitable for USP L1
• Produktlinie: LiChrospher^®
• Leistungsmerkmale: endcapped
• Verpackung: 1 ea of
• Kennzeichnungsgrad: 21.6% Carbon loading
• Parameter: 250 bar pressure; 60 °C max. temp.
• Methode(n): HPLC: suitable; mass spectrometry (MS): suitable (Low - Medium)
• Säule L × ID: 25 cm × 4 mm
• Oberflächenbereich: 350 m²/g
• Matrix: fully porous particle
• Aktive Matrixgruppe: C18 bonding phase
• Partikelgröße: 10 μm
• Porengröße: 100 Å pore size
• operating pH range: 2-7.5
• Trenntechnik: reversed phase
• Lagertemp.: no temp limit

Beschreibung

Allgemeine Beschreibung

HPLC cartridge

LiChrospher^® RP-18 endcapped is a reliable and versatile traditionally produced spherical silica gel carrier with C-18 endcapped reversed phase properties. It is well suited for the separation of neutral, acidic and weak basic compounds. This sorbent is packed into a LiChroCART 250-4 HPLC cartridge. The connection to the HPLC system is being accomplished by use of the manu-CART NT cartrige holder (1.51486).

Anwendung

• Integration of Solid-Phase Extraction and Reversed-Phase Chromatography in Single Protein-Coated Columns for Direct Injection of Bupivacaine in Human Serum: This study highlights the use of the LiChrosorb^® RP-8 HPLC column in a novel method integrating solid-phase extraction with reversed-phase chromatography. This approach significantly enhances the efficiency and accuracy of bupivacaine analysis in human serum, underscoring the column′s utility in clinical and pharmaceutical settings. The research demonstrates the column′s high performance in complex sample matrices, making it an invaluable tool for analytical chemists and researchers in drug monitoring and pharmacokinetics (Zarad et al., 2020).

Hinweis zur Analyse

Druck: ≤ 40 bar
Theoretische Bodenzahl (N/m) (Toluol): ≥ 20000
Symmetrie (Toluol): 0.8 - 1.4
Kapazitätsfaktor (Toluol): 1.5 - 3.0

Rechtliche Hinweise

LICHROCART is a trademark of Merck KGaA, Darmstadt, Germany

LiChrosorb is a registered trademark of Merck KGaA, Darmstadt, Germany

LiChrospher is a registered trademark of Merck KGaA, Darmstadt, Germany